EPB0129 | Role of low-risk HPV PCR in screening for HSIL lesions and anal cancer in men who have sex with men (MSM) living with HIV (MSM-LWHIV) | E-poster | Co-infections (including opportunistic infections) |
EPA0025 | Role of transcriptionally-active "defective" HIV-1 proviruses in immunological non-responders: a case-control study | E-poster | HIV pathogenesis |
EPC0520 | Roles of community health workers in advancing health security and resilient health systems: emerging lessons from the COVID 19 pandemic in Tanzania | E-poster | Epidemiology of COVID-19 |
TUPEB15 | Ruxolitinib-mediated HIV-1 reservoir decay in A5336 phase 2a trial | Poster exhibition | Other strategies and therapies |
MOPEB03 | Safety and efficacy of 6-month rifampicin resistant TB regimens in people living with HIV: final analysis | Poster exhibition | Co-infections (including opportunistic infections) |
EPC0484 | Same day ART initiation, loss to follow-up and viral load suppression among people living with HIV in low- and middle-income countries: a systematic review and meta-analysis | E-poster | Cascades of HIV care and treatment |
MOPEC17 | Same-day initiation of emtricitabine-tenofovir disoproxil succinate in a demedicalized model of oral pre-exposure prophylaxis (PrEP) in Mexico: a real-world data analysis | Poster exhibition | HIV prevention research |
OAC0503 | Same-day initiation of oral pre-exposure prophylaxis is high among adolescent men who have sex with men and transgender women in Brazil | Oral abstract session with live Q&A | Population-specific interventions for HIV prevention |
EPA0107 | SARS-CoV-2 infection and Spike protein exposure alter iPSC-derived human brain organoid homeostasis | E-poster | SARS-CoV-2 virology, pathogenesis, and host immune responses, vaccines and immunotherapies |
EPE0871 | Saturation of tuberculosis preventive therapy among people living with HIV, Mumbai, India | E-poster | Implementation science and scale up of treatment |